Discovery of a Potent (4<i>R</i>,5<i>S</i>)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling
Huifen Chen, Anthony A. Estrada, Po‐wai Yuen, Vishal Verma, Elisia Villemure(Unknown), Martin E. Dahl(Takeda (United States)), Wienke Lange(Evotec (Germany)), Shawn D. Erickson(The King's College), Justin Q. Ly, Baihua Hu, Christine Brotherton‐Pleiss(University of Hawaiʻi at Mānoa), Brian S. Safina, Rebecca M. Reese, Daniel G. Shore, Aleksandr Kolesnikov, Suzanne Tay, Joseph P. Lyssikatos, Lesley Murray(Leeds Teaching Hospitals NHS Trust), Shannon D. Shields, Xiaofeng Xu(Hangzhou Normal University), Matthew Volgraf, Lan Wang(Nanjing Second Hospital), Jun Chen(Abbott (United States)), Yong Chen, Yamin Zhang, Aijun Lu, Steven Do, David H. Hackos, Guosheng Wu, Desiree Amm(Evotec (Germany))
Cited by 39
Related Papers
TRPA1 as a drug target—promise and challenges
|Naunyn-Schmiedeberg s Archives of Pharmacology|2015|156
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
|Science Translational Medicine|2024|129
Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab
|Clinical Cancer Research|2009|124
Disruption of IRE1α through its kinase domain attenuates multiple myeloma
|Proceedings of the National Academy of Sciences|2019|115